GORACCI, Gianfrancesco
 Distribuzione geografica
Continente #
NA - Nord America 4.128
EU - Europa 3.026
AS - Asia 2.499
SA - Sud America 354
AF - Africa 56
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 3
AN - Antartide 1
Totale 10.072
Nazione #
US - Stati Uniti d'America 4.039
SG - Singapore 1.155
UA - Ucraina 626
IE - Irlanda 535
SE - Svezia 389
CN - Cina 361
RU - Federazione Russa 336
HK - Hong Kong 321
BR - Brasile 283
IT - Italia 272
DE - Germania 246
FI - Finlandia 179
VN - Vietnam 177
KR - Corea 153
FR - Francia 146
GB - Regno Unito 116
IN - India 65
TR - Turchia 62
CA - Canada 46
BE - Belgio 39
BD - Bangladesh 35
IQ - Iraq 33
PL - Polonia 30
UZ - Uzbekistan 27
AR - Argentina 24
CH - Svizzera 23
MX - Messico 21
NL - Olanda 20
ZA - Sudafrica 18
PK - Pakistan 16
CO - Colombia 13
ES - Italia 13
AT - Austria 12
SA - Arabia Saudita 12
ID - Indonesia 11
AE - Emirati Arabi Uniti 10
JP - Giappone 10
PH - Filippine 9
VE - Venezuela 9
GR - Grecia 8
MA - Marocco 8
CL - Cile 7
EG - Egitto 7
CZ - Repubblica Ceca 6
EC - Ecuador 6
JM - Giamaica 6
KZ - Kazakistan 6
MY - Malesia 6
TN - Tunisia 6
EU - Europa 5
IL - Israele 5
LT - Lituania 5
DZ - Algeria 4
LB - Libano 4
OM - Oman 4
PY - Paraguay 4
AL - Albania 3
AZ - Azerbaigian 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
HN - Honduras 3
JO - Giordania 3
KE - Kenya 3
PR - Porto Rico 3
RS - Serbia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
BN - Brunei Darussalam 2
HU - Ungheria 2
IM - Isola di Man 2
LV - Lettonia 2
LY - Libia 2
ME - Montenegro 2
NI - Nicaragua 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PE - Perù 2
PS - Palestinian Territory 2
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BS - Bahamas 1
BT - Bhutan 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
DK - Danimarca 1
EE - Estonia 1
IR - Iran 1
KG - Kirghizistan 1
MN - Mongolia 1
MT - Malta 1
MU - Mauritius 1
NP - Nepal 1
PA - Panama 1
PT - Portogallo 1
Totale 10.068
Città #
Singapore 759
Chandler 665
Dublin 535
San Jose 333
Jacksonville 324
Hong Kong 320
Ashburn 292
San Mateo 237
Boardman 171
Ann Arbor 165
Seoul 152
Santa Clara 136
Moscow 117
Medford 111
Princeton 108
Munich 98
Lauterbourg 94
Wilmington 93
Beijing 77
Andover 59
Piscataway 52
Dong Ket 45
Los Angeles 44
New York 44
Ho Chi Minh City 40
Des Moines 39
Brussels 38
Izmir 37
Turku 35
Perugia 33
Helsinki 31
Houston 31
São Paulo 29
Woodbridge 29
Orem 28
Altamura 26
Rome 26
Saint Petersburg 26
The Dalles 26
Hanoi 25
Shanghai 25
Frankfurt am Main 22
Auburn Hills 20
Dallas 19
Lawrence 19
Montreal 19
Norwalk 16
Baghdad 15
Falls Church 15
Milan 15
Warsaw 15
Brooklyn 14
Tashkent 14
Atlanta 13
Chicago 13
Denver 13
Chennai 12
Johannesburg 11
Belo Horizonte 10
Boston 10
London 10
Stockholm 10
Amsterdam 9
Mexico City 9
Toronto 9
Ankara 8
Città Di Castello 8
Mumbai 8
New Delhi 8
Rio de Janeiro 8
Tokyo 8
Guangzhou 7
Ottawa 7
Poplar 7
San Francisco 7
Betim 6
Da Nang 6
Dhaka 6
Ninh Bình 6
Phoenix 6
Secaucus 6
Brasília 5
Cairo 5
Changsha 5
Columbus 5
Dammam 5
Espoo 5
Grugliasco 5
Manchester 5
Redwood City 5
Seattle 5
Tianjin 5
Bexley 4
Biên Hòa 4
Busto Arsizio 4
Campinas 4
Carney 4
Charlotte 4
Cisterna di Latina 4
Council Bluffs 4
Totale 6.086
Nome #
L’infiltrazione intradetrusoriale di tossina botulinica A riduce i livelli tissutali vescicali di nerve growth factor in pazienti affetti da iperattività detrusoriale neurogena. 220
Activation of human platelet phospholipase A2 induced by phisiological agonist or fluoroaluminate: effec of inhibitors of protein kinases 177
Activation of phospholipase A2 and B-thromboglobulin release in human platelets: comparative effects of thrombin and fluoroaluminate stimulation. 176
Characterization of nuclear secretory phospholipase A2 (sPLA2) 159
Studio di un'attività fosfolipasica presente nei nuclei di cellule gliali e neuronali di corteccia cerebrale di ratto. 141
Characterization of a phospholipase A2 present in purified nuclei from rat brain cortex . INTERNATIONAL CONFERENCE ON PHOSPHOLIPASE A2 138
Misurazione del PAF (fattore attivante le piastrine) nella saliva umana; standardizzazione del metodo 135
PAF-synthesizing enzyme activities increase during long-term potentiation in the rat medial vestibular nuclei 126
Phospholipase A2 activity in rat brain nuclei. 125
The induction of long-term potentiation (LTP) in the medial vestibular nuclei enhances the activities of enzymes involved in the synthesis of platelet-activating-factor (PAF). 125
Immunolocalization of secretory phospholipases A2 (sPLA2) in neural cells 125
Group II phospholipase A2 (GIIA) is involved in neuritogenesis in NGF-treated PC12 cells. 122
Release of group IIA secretory phospholipase A2 from rat brain mitochondria: does it correlated with that of cytochrome c? 122
EFFECT OF NGF ON PHOSPHOLIPASES A2 LOCALIZATION IN PC12 CELLS 121
RELEASE OF GROUP IIA SECRETORY PHOSPHOLIPASE A2 FROM RAT BRAIN MITOCHONDRIA: DOES IT CORRELATE WITH THAT OF CYTOCHROME c? 120
Analysis by high performance liquid chromatography of the water-soluble precursors of choline and ethanolamine phosphoglycerides in the rat brain 119
Effect of NGF on the Subcellular Localization of Group IIA Secretory Phospholipase A2 (GIIA) in PC12 Cells: Role in Neuritogenesis. 116
Rat brain release a phospholipase A2 having properties similar those of the typr II secretory enzymes 115
Properties of phospholipase A2 in the nuclear fraction of rat brain cortex 115
The presence of a secretory phospholipase A2 in the nuclei of neuronal and glial cells of rat brain cortex. 113
Localisation and properties of Phospholipases A2 in rat brain cortex mithocondria assayed with labelled E.Coli membranes as substrates. 112
Botulinum A toxin intravesical treatment induces a reduction of nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity. 112
Mitochondrial localization of sPLA2-IIA in neuronal cell 112
Bladder tissue levels of nerve growth factor in patients with benign prostatic hyperplasia and detrusor overactivity treated with tamsulosin. 110
Cloricromene inhibits G-Protein mediated activation of phospholipase A2 in human platelets 110
NGF Induces the Expression of Group IIA Secretory Phospholipase A2 in PC12 Cells: The Newly Synthesized Enzyme Is Addressed to Growing Neurites 108
Botulinum-A toxin injections into the detrusor muscle reduce nerve growth factor bladder tissue levels in patients affected by neurogenic detrusor overactivity. 107
Is isoprostane 8-iso-PGF2a a reliable marker of different velico-sphincter dysfunction? 106
Characterization of a Phospholipases A2 present in purified nuclei from brain cortex 106
Role of Platelet activating factor in the long term potentiation of the rat medial vestibular nuclei. 105
Fusion of human platelets with cytidine-5-phospate loaded liposomes: effect on arachidonic acid release. 105
Choline plasmalogen biosynthesis by transmethylation in human platelets 105
Protein kinase C inhibitors enhance G-protein induced phospholipase A2 activation in intact human platelets 104
Brain secretory phospholipase A2: functions and roles in neurodegenerative diseases 104
Down-regulation of fluoroaluminate-induced release of arachidonic acid by protein kinase C is calcium-dependent and not related to secretory phospholipase A2 103
The release of arachidonic acid (AA ) by human platelets stimulated by fluoroaluminate and low concetration of collagene potentiated by inhibitors of protein kinase C (PKC). 102
Bladder tissue levels of NGF in SCI patients with detrusor overactivity before and after botulinum-A toxin injections into the detrusor muscle 102
BOTULINUM-A TOXIN INJECTIONS INTO THE DETRUSOR MUSCLE REDUCE NERVE GROWTH FACTOR BLADDER TISSUE LEVELS IN P A TIENTS AFFECTED BY NEUROGENIC DETRUSOR OVER- ACTIVITY 102
Characterization of rat brain phospholipases A2 and their possible role in cellular signaling 101
Group B streptococcus (GBS) causes macrophage PLA2s activation and modification of phosphatidyl- serine metabolism during induction of apoptosis 101
CHARACTERIZATION OF NUCLEAR SECRETORY PHOSPHOLIPASE A2 (sPLA2) 101
Botulinum A toxin intradetrusorial injections modulate the bladder expression of NGF, TRKA, P75 and TRPV1 in patients with detrusor overactivity. 100
Distribution of secretory phospholipase A2 (PLA2) in neural cells 100
Immunolocalization of secretory phospholipases A2 (sPLA2) in neural cells 99
Platelet activating factor : a potential retrograde messenger in long term potentiation of the rat medial vestibular nuclei. 98
Brain secreted phospholipases A2 (sPLA2) as intra- and extra-cellular mediators 98
Platelet-activating factor and group I metabotropic glutamate receptors interact for full development and maintenance of long-term potentiation in the rat medial vestibular nuclei. 97
Nerve Growth Factor bladder tissue levels in patients with benign prostatic hyperplasia and detrusor overactivity treated with tamsulosin. 96
The synthesis of choline and etrhanolamine phosphoglycerides in neuronal and glial cells of rabbit in vitro. 96
Determination of nerve growth factor levels into human bladder wall by modified enzyme-linked immunoabsorbent assay. 95
Brain mitochondrial phospholipases A2: functions and role in cell death 95
High pressure liquid chromatography (HPLC) of water-soluble precursors of choline and ethanolamine phosphoglycerides in animal tissues 95
Brain secretory phospholipases A2: role in neurodegeneration. 94
Lipid metabolism during early ischemia 93
Subcellular localization of secretory phospholipases A2 (sPLA2) group IIA (GIIA) and group V (GV) in neural cells 93
Botulinum-A toxin injections into the detrusor muscle decrease nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity 93
Presence of Group V Phospholipase A2 in rat brain cortex nuclei. 91
Involvement of group IIA secretory phospholipase A2 (GIIA) in NGF-induced neuritogenesis of PC12 cells 91
Mitochondrial and nuclear secretory phospholipases A2: potential partecipation to life or death decision of neural cells. 90
Cholinephosphotransferase activity in human platelet 90
Effect of protein kinase inhibitors on HFS-induced long term potentiation and activation of PAF-synthesizing enzymes in rat medial vestibular nuclei. 89
Enhancement of PAF-synthesizing enzyme activities during long-term potentiation (LTP) in rat brain-stem slices 89
Is the cytosolic phospholipase A2 the enzyme that is activated by a G- protein-mediated mechanism in human platelets and is down-regulated by protein kinase C ? 88
Reversible inhibition of hydrogen peroxide elimination by calcium in brain mitochondria 88
Presence of Group V Phospholipase A2 in rat brain cortex nuclei 88
The metabolism of labelled ethanolamine in neuronal and glial cells of the rabbit in vivo. 87
Metabolism and Functions of Platelet-Activating Factor (PAF) in the Nervous Tissue 86
Enzymic synthesis of 1-alkyl-2-acyl-sn-glycero-3-phosphorylethanolamine through ethanolaminephosphotransferase activity in the neuronal and glial cells of rabbit in vitro 85
Enzymic synthesis of ethanolamine plasmalogens through ethanolaminephospho-transferase activity in neurons and glial cells of rabbit in vitro 85
Low molecular weight phospholipases A2 in mammalian brain and neural cells: roles in functions and dysfunctions. 83
Release of a phospholipase a2 from rat brain mithocondria. 83
Nerve Growth factor bladder tissue levels in patients with neurogenic detrusor overactivity before and after botulinum-A toxin injections into the detrusor muscle 82
The effects of Calcium on reactive oxygen species elimination in brain mitochondria 82
Properties of phospholipase A2 in the nuclear fraction of rat brain cortex. European Society of Neurochemistry and International Society of Neurochemistry (ESN-ISN) 81
The bladder urothelium: passive permeability and intravesical drug passive diffusion. 81
The presence of a secretory phospholipase A2 in the nuclei of neuronal and glial cells of rat brain cortex 80
Trattamento dei disturbi vescicali sensitivi con tossina botulinica A: studio pilota 79
Protein kinase C inhibitors enhance G-protein induced phospholipase A2 activation in intact human platelets 79
Secretory phospholipases A2 in neural cells: localization and functions 78
The effect of calcium on reactive oxygen species elimination in brain mitochondria 77
Platelet-activating factor: role in long-term potentiation and in brain damage 77
Inhibition of PAF synthesis by stimulated human polymorphonuclear leucocytes with cloricromene, an inhibitor of phospholipase A2 activation 75
Evidence that cytosolic phospholipase A2 is down-regulated by protein kinase C in intact human platelets stimulated with fluoroaluminate. 74
Role of protein kinase C in the release of arachidocic acid from platelets 74
Membrane phosphatidylcholine pools and synthetic mechanisms. 73
Role of Platelet-Activating Factor in long-term potentiation of the medial vestibular nuclei. 73
PAF levels in saliva are regulated by inflammatory cells 73
Determination of Nerve Growth Factor levels into human bladder wall by modified enzyme-linked immunoabsorbent assay. 72
Involvment of group IIA phospholipase A2 (GIIA) in NGF-induced neuritogenesis of PC12 cells 71
Cloricromene inhibits leukotriene formation by human polymorphonuclear leukocytes by suppressing arachidonate release from membrane phospholipids. 71
Metabolism and functions of phosphatidylserine in mammalian brain. 71
Metabolic studies on ethanolamine phosphoglycerides in neuronal and glial cells. 70
Low Molecular Weight Phospholipases A2 in Mammalian Brain and Neural Cells: Roles in Functions and Dysfunctions 69
Respiratory state and release of mitochondrial phospholipase A2 69
Livelli tissutali di Nerve growth factor nella ipertrofia prostatica benigna ed iperattività detrusoriale dopo terapia con tamsulosina. 68
Phospholipase A2 release from rat brain cortex mitochondria depends on respiratory state and precedes the liberation of cytochrome c 67
Group IIA secretory phospholipase A2 (GIIA) mediates apoptotic death during NMDA receptor activation in rat primary cortical neurons. 66
Rat brain cortex mitochondria release group II secretory phospholipase A(2) under reduced membrane potential. 66
Metabolism and functions of Platelet-Activating Factor in the nervous tissue. 64
Neural Lipids 64
Totale 9.809
Categoria #
all - tutte 40.774
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.774


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021187 0 0 0 0 0 0 0 0 0 0 109 78
2021/2022961 25 192 30 68 43 12 19 259 12 33 99 169
2022/20231.779 141 203 27 187 136 209 2 100 682 4 61 27
2023/2024669 34 69 31 6 10 9 174 24 91 7 135 79
2024/20251.440 47 178 102 51 193 42 30 105 258 71 228 135
2025/20263.084 242 198 148 442 443 282 501 134 365 257 72 0
Totale 10.276